Skip to content

Clinical trials

Phase 2 Dermatitis, Atopic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 2 Country / region: China Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20191
20202
20213
20225
202313
20243
202511
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting10
Not yet recruiting4
Unknown status4
Terminated3
Active, not recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Keymed Biosciences Co.Ltd8
Akeso3
GlaxoSmithKline2
Innovent Biologics (Suzhou) Co. Ltd.2
Jiangsu vcare pharmaceutical technology co., LTD2
Lynk Pharmaceuticals Co., Ltd2
Pfizer2
Shanghai Mabgeek Biotech.Co.Ltd2
Celgene1
Chengdu Zenitar Biomedical Technology Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic45
Eczema6
Dermatitis3
Immune System Diseases2
Bile Duct Diseases1
Biliary Tract Diseases1
Cholangitis1
Cholangitis, Sclerosing1
Digestive System Diseases1
Liver Cirrhosis, Biliary1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.